Account

Industry resources and insights

Sort by year
  • All time
  • 2026
  • 2025
  • 2024
  • 2023
  • 2022
  • 2021
  • 2020 and older
Articles
12.01.2026
If You’re a Market Access Lead in 2026: What W...

Have you ever wondered what separates the organisations that consistently secure unhindere...

Read more
Articles
03.12.2025
Market Access & Pricing Trends for 2026

The Top Market Access Trends for 2026 The market access trends 2026 are being shaped by increasing g...

Read more
News
03.12.2025
Joint Scientific Consultations 2026 – key dates ...

The HTA Coordination Group (HTACG) has now confirmed the 2026 request periods for joint scientific c...

Read more
Insider Insights
26.11.2025
ISPOR Europe 2025: Key Insights, Research Posters ...

ISPOR Europe 2025 brought together global HTA bodies, payers, industry leaders and patient organisat...

Read more
Articles
26.11.2025
2025 Market Access Check-In: Evaluating the Impact...

2025 was a pivotal year for market access, marked by the growing convergence between scientific inno...

Read more
Articles
03.11.2025
Designing Payer-Ready Trials in 2025: Five Decisio...

Clinical innovation has never moved faster. Tools like single-arm designs, novel surrogates, and ada...

Read more
Load more
Browse by topic
  • Advanced Therapy Medicinal Products
  • Alzheimer’s
  • BD Assessments
  • Biosimilars
  • Biotech
  • Devices & Diagnostics
  • Digital Health
  • Early Access
  • Early Payer Dialogue
  • Emerging & Developing Markets
  • Funding
  • Gene Therapy & ATMPs
  • HTA
  • International Reference Pricing
  • ISPOR
  • Launch
  • Managed Entry Agreements
  • Market Access Trends
  • Medicine manufacturing
  • MFN
  • NICE
  • Oncology
  • Orphan Drugs
  • PMA Trends
  • Pricing
  • Rare Diseases
  • Real World Evidence
  • Team Remap
  • Tendering & Procurement
  • Training
  • United States
Content type
  • All
  • Articles
  • Case Studies
  • Checklist
  • Guide
  • Insider Insights
  • News
  • Poster
  • Publications
  • Webinar
Subscribe
This field is for validation purposes and should be left unchanged.
This field is hidden when viewing the form
Consent

Talk to an expert

Remap Consulting have significant experience working with pharmaceutical and biotech companies in helping them navigate global market access.​

Get in touch